IM8, the nutrition and wellness company co-founded by David Beckham, has secured $1 billion from General Catalyst, an investment drawn from the firm's unusually structured Consumer Ventures Fund. The size of the check, and the vehicle behind it, make the deal one of the most closely watched consumer investments of the year, and a referendum on whether celebrity-founded health brands can be built into durable, science-adjacent businesses.
IM8 sells a daily nutritional supplement positioned around longevity, clean ingredients and performance, riding a wave of consumer enthusiasm for products that promise measurable health benefits. Beckham's involvement brings global reach in a category where attention is the scarcest resource, but the company has emphasized formulation, sourcing and a direct-to-consumer-plus-retail strategy designed to outlast the celebrity news cycle.
General Catalyst's Consumer Ventures Fund is the reason the round is historic. CVF is built to write enormous checks for consumer companies, a category venture capital has starved for a decade, using a structure that blends equity, debt and long-dated capital so consumer brands can scale without the growth rates software investors demand. The fund has already backed companies like Skims and Fanatics, and $1 billion for IM8 signals how aggressively it intends to operate.
Critics see a valuation driven by hype; believers see founder-market fit between a global star and a product in the fastest-growing corner of wellness. The next phase for IM8 is execution: international expansion, retail partnerships and proof that a billion dollars can turn a supplement brand into a consumer empire.
